Anna Rose Welch talks about a new whitepaper that explains why now is the best time for a U.S. biosimilars shared savings model.
Show References & Notes:
Why It's Time For A U.S. Biosimilar Shared Savings Model
The whitepaper by Matrix Global Advisor’s Alex Brill
Articles By Anna Rose Welch
Email Anna Rose Welch at firstname.lastname@example.org
Music in this episode provided by Abby Wright.